当前位置: X-MOL 学术J. Nat. Prod. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tiacumicin Congeners with Improved Antibacterial Activity from a Halogenase-Inactivated Mutant
Journal of Natural Products ( IF 5.1 ) Pub Date : 2018-04-20 00:00:00 , DOI: 10.1021/acs.jnatprod.7b00990
Haibo Zhang 1 , Xiaoxing Tian 2 , Xiaohui Pu 2 , Qingbo Zhang 1 , Wenjun Zhang 1 , Changsheng Zhang 1
Affiliation  

Tiacumicin B (1, also known as fidaxomicin or difimicin) is a marketed drug for the treatment of Clostridium difficile infections. The biosynthetic pathway of 1 has been studied in Dactylosporangium aurantiacum subsp. hamdenensis NRRL 18085 and has enabled the identification of TiaM as a tailoring dihalogenase. Herein we report the isolation, structure elucidation, and bioactivity evaluation of 14 tiacumicin congeners (including 11 new ones) from the tiaM-inactivated mutant. A new tiacumicin congener, 3, with a propyl group at C-7‴ of the aromatic ring was found to exhibit improved antibacterial activity.

中文翻译:

Tiacumicin同源物,具有卤素酶灭活突变体改善的抗菌活性。

Tiacumicin B(Tiacumicin B ,替卡米星B ,Tiacumicin B ,Tiacumicin B)(1,也称为非达索霉素(fidaxomicin,difimicin))是一种用于治疗艰难梭菌感染的市售药物。的生物合成途径1进行了研究孢囊橙黄亚种。hamdenensis NRRL 18085,并已将TiaM鉴定为特制的二卤化酶。在此,我们报告了从tiaM失活突变体中分离出的14种tiacumicin同系物(包括11个新的同系物)的分离,结构解析和生物活性评估。发现一种新的头孢菌素同源物3在芳香环的C-7′处带有一个丙基,具有更好的抗菌活性。
更新日期:2018-04-20
down
wechat
bug